6651 - 6700 of 8620 Results
Title
Year
- Real-world assessment of “OFF” episode–related healthcare resource utilization among patients with Parkinson’s disease in the United States2021OPENTitle: Real-world assessment of “OFF” episode–related healthcare resource utilization among patients with Parkinson’s disease in the United StatesJournal Name: Journal of Medical EconomicsPublisher: Informa UK LimitedVol: 24Issue #: 1Start Page: 540End Page: 549Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/13696998.2021.1913009Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.1913009?needAccess=trueCitation Count: 5
-
RESTRICTEDTitle: The Impact of Cloud Management Platforms on Nonprofit Business ModelsJournal Name: Journal of Technology in Human ServicesPublisher: Informa UK LimitedVol: 39Issue #: 4Start Page: 405End Page: 425Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/15228835.2021.1920556Citation Count: 5
- Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and Falling2021OPENTitle: Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and FallingJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1957End Page: 1964Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212636Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212636?id=journal-of-parkinsons-disease%2Fjpd212636Citation Count: 15
- Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imaging2021OPENTitle: Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imagingJournal Name: Seminars in Arthritis and RheumatismPublisher: Elsevier BVVol: 51Issue #: 5Start Page: 1125End Page: 1133Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.semarthrit.2021.08.004Best OA location URL: https://research.vumc.nl/en/publications/d083f460-428b-4cc9-b64c-8e646fc9a1c6Citation Count: 23
- Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosis2021OPENTitle: Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosisJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 84Issue #:Start Page: 343End Page: 351Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.sleep.2021.06.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8355084Citation Count: 6
- How firms undertake organizational changes to shift to more-exploratory strategies: A process perspective2020OPENTitle: How firms undertake organizational changes to shift to more-exploratory strategies: A process perspectiveJournal Name: Research PolicyPublisher: Elsevier BVVol: 50Issue #: 1Start Page: 104118End Page: 104118Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.respol.2020.104118Best OA location URL: https://minesparis-psl.hal.science/hal-02943926Citation Count: 22
-
RESTRICTEDTitle: Optimal Treatment of Depression and Anxiety in Parkinson's DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 6Start Page: 530End Page: 540Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2021.02.037Citation Count: 50
-
OPENTitle: Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 27End Page: 32Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.024Best OA location URL: https://doi.org/10.1016/j.parkreldis.2021.07.024Citation Count: 17
- The Importance of Cross-Disciplinary Research: A Commentary on “Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease”2021RESTRICTEDTitle: The Importance of Cross-Disciplinary Research: A Commentary on “Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease”Journal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 9Start Page: 969End Page: 971Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2021.01.010Citation Count: 0
- Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients2021OPENTitle: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 25End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012Best OA location URL: http://www.prd-journal.com/article/S1353802021001450/pdfCitation Count: 19
-
RESTRICTEDTitle: Coincident parkinsonism and myasthenia gravis: A case seriesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 4End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.016Citation Count: 7
-
RESTRICTEDTitle: Impact of the apolipoprotein E ε4 allele on early Parkinson's disease progressionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 66End Page: 70Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.004Citation Count: 10
- A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study2021RESTRICTEDTitle: A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 90End Page: 97Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.034Citation Count: 13
-
OPENTitle: North American survey on impact of the COVID-19 pandemic shutdown on DBS careJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 41End Page: 45Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.011Best OA location URL: http://www.prd-journal.com/article/S1353802021003667/pdfCitation Count: 7
- Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scores2021OPENTitle: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scoresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 74End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003Best OA location URL: https://hal.archives-ouvertes.fr/hal-03298502Citation Count: 8
-
RESTRICTEDTitle: Serum neurofilament light chain predicts future freezing of gait in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 102End Page: 104Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.015Citation Count: 8
- Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database2021OPENTitle: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI databaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 34End Page: 37Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007Best OA location URL: https://repositorio.uca.edu.ar/handle/123456789/11625Citation Count: 12
-
OPENTitle: Falling down the digital divide: A cautionary taleJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 93Issue #:Start Page: 33End Page: 34Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.032Best OA location URL: http://www.prd-journal.com/article/S1353802021003953/pdfCitation Count: 4
-
RESTRICTEDTitle: Visual dysfunction is associated with cognitive impairment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.005Citation Count: 11
- Compound heterozygous variants in Wiskott-Aldrich syndrome like (WASL) gene segregating in a family with early onset Parkinson's disease2021OPENTitle: Compound heterozygous variants in Wiskott-Aldrich syndrome like (WASL) gene segregating in a family with early onset Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 61End Page: 67Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.001Citation Count: 9
-
RESTRICTEDTitle: Increased functional connectivity in a population at risk of developing Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.026Citation Count: 8
- Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)2020OPENTitle: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 133End Page: 137Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdfCitation Count: 5
- A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study2021OPENTitle: A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 128End Page: 133Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.013Best OA location URL: http://www.prd-journal.com/article/S1353802021002625/pdfCitation Count: 24
-
RESTRICTEDTitle: Telemedicine and Deep brain stimulation - Current practices and recommendationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 199End Page: 205Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.001Citation Count: 25
-
OPENTitle: Plasma NfL, clinical subtypes and motor progression in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 41End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.016Citation Count: 42
- Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experience2021OPENTitle: Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experienceJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 66End Page: 76Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.018Best OA location URL: http://www.prd-journal.com/article/S1353802021003126/pdfCitation Count: 17
- Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach2021RESTRICTEDTitle: Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approachJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 124End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.05.011Citation Count: 19
- Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications2021OPENTitle: Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medicationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 59End Page: 66Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.009Best OA location URL: http://www.prd-journal.com/article/S1353802021003643/pdfCitation Count: 49
- Consistent skin α-synuclein positivity in REM sleep behavior disorder – A two center two-to-four-year follow-up study2021RESTRICTEDTitle: Consistent skin α-synuclein positivity in REM sleep behavior disorder – A two center two-to-four-year follow-up studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 108End Page: 113Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.007Best OA location URL: http://hdl.handle.net/11380/1251595Citation Count: 23
- Diffusion along perivascular spaces reveals evidence supportive of glymphatic function impairment in Parkinson disease2021OPENTitle: Diffusion along perivascular spaces reveals evidence supportive of glymphatic function impairment in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 98End Page: 104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8429254Citation Count: 114
- Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's disease2021OPENTitle: Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 22End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.016Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9310432Citation Count: 8
-
OPENTitle: Diagnostic criteria for blepharospasm: A multicenter international studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 109End Page: 114Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9048224Citation Count: 30
-
OPENTitle: Attentional dysfunction and the punding spectrum in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 23End Page: 28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.019Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7980283Citation Count: 10
- Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central Europe2021OPENTitle: Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central EuropeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 48End Page: 51Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.026Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8192481Citation Count: 13
-
OPENTitle: Skin conditions in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 40End Page: 46Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.018Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8900714Citation Count: 3
- Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study2021OPENTitle: Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 79End Page: 85Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.024Best OA location URL: http://www.prd-journal.com/article/S135380202100016X/pdfCitation Count: 65
- Motor Thalamic Deep Brain Stimulation Alters Cortical Activity and Shows Therapeutic Utility for Treatment of Parkinson’s Disease Symptoms in a Rat Model2021RESTRICTEDTitle: Motor Thalamic Deep Brain Stimulation Alters Cortical Activity and Shows Therapeutic Utility for Treatment of Parkinson’s Disease Symptoms in a Rat ModelJournal Name: NeurosciencePublisher: Elsevier BVVol: 460Issue #:Start Page: 88End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.02.019Citation Count: 6
-
OPENTitle: Investigating ELOVL7 coding variants in multiple system atrophyJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 749Issue #:Start Page: 135723End Page: 135723Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2021.135723Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7983070Citation Count: 2
- The association between multiple risk factors, clinical correlations and molecular insights in Parkinson’s disease patients from Tamil Nadu population, India2021RESTRICTEDTitle: The association between multiple risk factors, clinical correlations and molecular insights in Parkinson’s disease patients from Tamil Nadu population, IndiaJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 755Issue #:Start Page: 135903End Page: 135903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2021.135903Citation Count: 22
- ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study2021OPENTitle: ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 139End Page: 145Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.024Best OA location URL: http://www.prd-journal.com/article/S1353802021003539/pdfCitation Count: 38
- Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head trauma2020OPENTitle: Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head traumaJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 150Issue #:Start Page: 105237End Page: 105237Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.105237Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0969996120305131?via%3DihubCitation Count: 20
- Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation2021OPENTitle: Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 157Issue #:Start Page: 105426End Page: 105426Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105426Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105426Citation Count: 12
- Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cells2021OPENTitle: Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cellsJournal Name: Neurochemistry InternationalPublisher: Elsevier BVVol: 147Issue #:Start Page: 105070End Page: 105070Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuint.2021.105070Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7610942Citation Count: 23
- Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation study2021OPENTitle: Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation studyJournal Name: Neuroimage: ReportsPublisher: Elsevier BVVol: 1Issue #: 3Start Page: 100026End Page: 100026Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ynirp.2021.100026Best OA location URL: https://doi.org/10.1016/j.ynirp.2021.100026Citation Count: 17
- Temporal proteomics during neurogenesis reveals large-scale proteome and organelle remodeling via selective autophagy2021OPENTitle: Temporal proteomics during neurogenesis reveals large-scale proteome and organelle remodeling via selective autophagyJournal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 24Start Page: 5082End Page: 5098.e11Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.molcel.2021.10.001Best OA location URL: http://www.cell.com/article/S1097276521008005/pdfCitation Count: 73
- Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease2021RESTRICTEDTitle: Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 186Issue #:Start Page: 108465End Page: 108465Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108465Citation Count: 17
-
RESTRICTEDTitle: Quantitative Cellular Changes in the Thalamus of Patients with Multiple System AtrophyJournal Name: NeurosciencePublisher: Elsevier BVVol: 459Issue #:Start Page: 142End Page: 152Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.02.003Citation Count: 4
- The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A442021OPENTitle: The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A44Journal Name: Molecular Genetics and MetabolismPublisher: Elsevier BVVol: 133Issue #: 1Start Page: 109End Page: 112Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.ymgme.2021.03.012Best OA location URL: https://doi.org/10.1016/j.ymgme.2021.03.012Citation Count: 3
- Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammation2020OPENTitle: Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammationJournal Name: Mucosal ImmunologyPublisher: Elsevier BVVol: 14Issue #: 3Start Page: 652End Page: 666Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1038/s41385-020-00354-7Best OA location URL: https://www.nature.com/articles/s41385-020-00354-7.pdfCitation Count: 34
- Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo2021OPENTitle: Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivoJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 29Issue #: 9Start Page: 2821End Page: 2840Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymthe.2021.04.035Best OA location URL: http://www.cell.com/article/S1525001621002495/pdfCitation Count: 38